Research
The Division of Pediatric Endocrinology and Diabetes at Stanford is actively involved in clinical research. If you are interested in being contacted about future studies, please complete the Patient List Research Consent Form. Once completed and submitted, the information you provide will be added to our database of potential research participants.
Diabetes Studies
Studies Currently Recruiting
Recruitment Database
This Redcap database - a list of all patients who have indicated interest in being contacted for participation in Stanford Diabetes Research (T1D + T2D). https://redcap.link/t1dt2dresearch.
Main Eligibility Criteria:
-Ages 2– 70 years
-T1D and T2D
-Any device or mode of insulin delivery
-Currently English only
Contact:
PI: Darrell Wilson, MD
Lead CRC: Sarah Hanes sjhanes@stanford.edu
Pathway to Prevention (TrialNet)
Phase 1 Screening: testing for presence of diabetes related autoantibodies. Phase 2 Monitoring: Annual retesting if one autoantibody is positive; Semi-annual study visits if 2 or more autoantibodies are positive. Potential entry into T1D prevention studies.
Main Eligibility Criteria:
-Ages 2.5 – 45 years
-Relatives of patients with T1D
-English and Spanish Speakers
-Please discuss subjects with PI first
-Duration Time for Pt in Study: Screening: 1 visit Positive autoantibodies
Contact:
PI: Priya Prahalad, MD, PhD & Darrell Wilson, MD
Lead CRC: Alondra Loyola aloyola1@stanford.edu
DiabetesWise for Exercise
The Aim of this project is to make it easier for people with diabetes and their healthcare providers (HCPs) to access and utilize vetted, helpful exercise and physical activity (PA) guidance.
Main Eligibility Criteria:
-Ages 18 years and over
-T1D or T2D for at least 6 months
-Currently using a CGM and Insulin
-Able to safely exercise
-Willing to use a fitness tracker for the duration of the study
-English Speaking/Reading fluency
-Must have compatable smart device
-Duration Time for Pt in Study - 3 months
Contact:
PI: Dessi Zaharieva
Lead Research Coordinator: Lindsay Jacobsohn lrjacobs@stanford.edu
SPEED PA
Participants who attend the SPEED class will be given the opportunity to join the tracker study to wear a physical activity tracker to observe how exercise impacts blood glucose.
Main Eligibility Criteria:
-Ages 11-21 years
-T1D only
-Must complete SPEED class prior to enrollment
-Duration Time for Pt in Study: At least 20 Months
Contact:
PI: Dessi Zaharieva, PhD
Lead CRC: Lindsay Jacobsohn lrjacobs@stanford.edu
Pre-Pro Insulin (Bio-Banking)
We hope to learn why some individuals develop T1D while others don’t by looking at pre-proinsulin and the immune response.
Main Eligibility Criteria:
-Ages 2 – 70 years
-T1D, T2D, Family Member of T1D, Controls
-Duration Time: 1 Blood Draw unless wanting to give blood again
Contact:
PI: Kent Jensen, PhD; Everett Meyer, MD, PhD
Lead CRC: Abby Twoy atwoy@stanford.edu
Other Endocrine Studies
PWS-Non-Invasive Vagus Nerve Stimulation
A Clinical Evaluation of Non-Invasive Vagus Nerve Stimulation for Temper Outbursts in People With PWS (VNS4PWS) in Prader-Willi Syndrome
Main Eligibility Criteria:
-Ages 10-40 yrs
-English speaking
-Duration Time: 2 years including Open Label Extension
Contact:
PI: Diane Stafford, MD
Lead CRC: Alondra Loyola aloyola1@stanford.edu
Mission Statement
Our mission is to innovate basic, translational, and clincial research in endocrinology and diabetes grounded in the principles of excellence and equity to advance scientific knowledge and improve the lives of all.
Stanford Diabetes Research Center
The SDRC promotes the teaching and training goals of Stanford University by training the next generation of investigators and leaders of diabetes research and care.
Basic Research
The aim of our basic science program is to elucidate the role of the endocrine system in both health and the development of diseases. Through this work, we hope to increase our understanding of the important physiological processes that are controlled by hormones and how alterations in hormone levels perturb the body’s homeostasis and cause disease in people. Our goal is to apply discoveries we make in the laboratory toward the development of novel therapeutics for a variety of illnesses that affect children.
You can read more about the work of faculty member Anna Gloyn and her team.
Research Database
Join our database to receive study recruitment emails. Click the button below.